Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Correction to: Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic ActionCurrent Psychiatry Reports · 2026-06-04Current status and future prospects of research on psilocybin's regulation of neurotransmitters and their receptors related to the pathogenesis of tinnitusHearing Research · 2026-06-03Rapid and Sensitive Detection of Psilocybin and Psilocin in Urine by Surface-Enhanced Raman SpectroscopyJournal of Raman Spectroscopy · 2026-05-27Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-27Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder.Unknown journal · 2026-05-25Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyUnknown journal · 2026-05-07Effects of Psilocybin Treatment on Cognitive Effort Avoidance in Major Depressive Disorder and Co-Occurring Alcohol Use DisorderUnknown journal · 2026-05-011080 Psilocybin Elicits Non-Linear Night to Night Changes in Sleep Spectral PowerSLEEP · 2026-04-30Psilocybin reshapes cortical inhibition through selective interneuron recruitmentbioRxiv · 2026-04-16The astrocytes in the prefrontal cortex contribute to the rapid antidepressant-like effects of psilocybin in the chronic restraint stress mouse modelProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-03-31Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping reviewJournal of Psychedelic Studies · 2026-03-08Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trialJournal of Affective Disorders · 2026-02-15Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applicationsProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-01-26Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacyGeneral Hospital Psychiatry · 2026-01-18Single-dose psilocybin promotes cell-type-specific changes of neurons in the orbitofrontal cortexNeurotherapeutics · 2025-12-31Psilocybin Production With Genetically Modified Aspergillus nidulans Under Pressurized ConditionsBiotechnology and Bioengineering · 2025-12-29From fungi to pharmacy: Applied technologies in psilocybin production and its therapeutic applicationsCreative Science · 2025-12-18Psilocybin Maintains Better Brain Function in an Alzheimer’s Disease Model with Reduced Neuroinflammation and Improved Hippocampal NeurogenesisUnknown journal · 2025-11-30Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch NegativitybioRxiv · 2025-11-06Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigmUniversität Zürich, ZORA · 2025-11-04Psilocybin and chronic neuropathic pain: a systematic review.Unknown journal · 2025-11-04Legal and Regulatory Barriers to Medical Psilocybin Use: An International OverviewUnknown journal · 2025-10-01Epigenome-wide Association Study of Psilocybin-Induced Methylome Changes in Alcohol Use DisorderbioRxiv · 2025-07-17The Medial PrefrontalCortex Modulates Psychedelic-likeEffects of PsilocinFigshare · 2025-07-07The Medial Prefrontal Cortex Modulates Psychedelic-like Effects of PsilocinACS Pharmacology & Translational Science · 2025-07-07Exploring serotonergic psychedelics as a treatment for personality disorders.Neuropharmacology · 2025-06-30Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depressionJournal of Psychopharmacology · 2025-06-30Correction: Psilocybin's acute and persistent brain effects: a precision imaging drug trials.Scientific data · 2025-06-17Psilocybin’s acute and persistent brain effects: a precision imaging drug trialScientific Data · 2025-06-04Understanding the Psychological Effects of Psilocybin and 3,4-Methylenedioxymethamphetamine in a Non-Clinical PopulationmedRxiv · 2025-05-28Psilocybin and Obsessive-Compulsive Disorder: Exploring New Therapeutic HorizonsNeuroscience Bulletin · 2025-05-13Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische AnwendungNervenheilkunde · 2025-04-30Divergent Effects of Psilocybin for 2 Patients Participating in a Psilocybin-assisted Cognitive Behavioral Therapy Trial for Major Depressive Disorder.Unknown journal · 2025-04-30595. Psilocybin-Assisted Therapy for Relapse Prevention in Alcohol Use Disorder: A RCTBiological Psychiatry · 2025-04-08Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trialUniversität Zürich, ZORA · 2025-03-31Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étudeThe Canadian Journal of Psychiatry · 2025-03-24Structural basis for psilocybin biosynthesisNature Communications · 2025-03-21A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Unknown journal · 2025-02-26Clinical Trial Comparing Psilocybin to Nicotine Patch for Tobacco AddictionDrug and Alcohol Dependence · 2025-01-31Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective.Expert review of neurotherapeutics · 2025-01-31Single-nucleus transcriptomics reveals cell type-specific and time-dependent effects of psilocybin and ketamine on gene expressionbioRxiv · 2025-01-03Psilocybin increases emotional empathy in patients with major depressionMolecular Psychiatry · 2024-12-17Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II DisorderPsychedelic Medicine · 2024-11-17Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.Unknown journal · 2024-11-12Optimized psilocybin production in tryptophan catabolism-repressed fungiMicrobial Biotechnology · 2024-10-31Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch NegativityResearch Square · 2024-09-25Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialEClinicalMedicine · 2024-09-22Psilocybin desynchronizes the human brainNature · 2024-07-16Prevalence of Psilocybin and Cannabis Concurrent Use During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health StudyDrug and Alcohol Dependence · 2024-06-30High Blood Pressure Among Psilocybin and Cannabis Consumers During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health StudyDrug and Alcohol Dependence · 2024-06-30The influence of psilocybin on subconscious and conscious emotional learningiScience · 2024-05-18Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With Caution.Unknown journal · 2024-05-08In vitro and in vivo metabolism of psilocybin’s active metabolite psilocinFrontiers in Pharmacology · 2024-04-28Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in miceJournal of Psychopharmacology · 2024-04-27Author Correction: Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.Unknown journal · 2024-04-22Fallbeispiele zur Therapie der rezidivierenden Depression mit PsilocybinNervenheilkunde · 2024-03-31Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditationScientific Reports · 2024-03-25Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive DisorderInternational Journal of Mental Health and Addiction · 2024-03-06The effect of psilocybin on empathy and prosocial behavior: a proposed mechanism for enduring antidepressant effectsnpj Mental Health Research · 2024-02-19Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depressionPsychological Medicine · 2024-01-21Psilocybin Promotes Cell-Type-Specific Changes in the Orbitofrontal Cortex Revealed by Single-Nucleus RNA-seqbioRxiv · 2024-01-06Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of PsilocybinBiological Psychiatry · 2024-01-04Psilocybin vs Escitalopram for depression: 6-month follow-upNeuroscience Applied · 2023-12-31Associations between behavioral and neuronal changes in self-referential processing following a single, moderate dose of psilocybin in depressed patientsNeuroscience Applied · 2023-12-31Psilocybin and Other Classic Psychedelics in Depression.Unknown journal · 2023-12-31Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differencesScientific Reports · 2023-10-13Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdalaNeuropsychopharmacology · 2023-09-25Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment DevelopmentPsychedelic Medicine · 2023-09-05Psilocybin desynchronizes brain networksmedRxiv · 2023-08-23Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM.Unknown journal · 2023-07-18Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trialBJPsych Open · 2023-06-30Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants.Unknown journal · 2023-06-25Personality change in a trial of psilocybin therapy v. escitalopram treatment for depressionPsychological Medicine · 2023-06-01[Psilocybin-Assisted Treatment of Depression, Anxiety and Substance use Disorders: Neurobiological Basis and Clinical Application].Unknown journal · 2023-05-18A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depressionJournal of Psychopharmacology · 2023-04-24Systematic Review of Interventions for Demoralization in Patients With Cancer.Unknown journal · 2023-03-31Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'.Unknown journal · 2023-01-29Psychedelics for Patients With Cancer: A Comprehensive Literature Review.Unknown journal · 2023-01-11Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trialEClinicalMedicine · 2022-12-27Canalization and plasticity in psychopathology.Unknown journal · 2022-12-26Neural mechanisms of psychedelic visual imagerymedRxiv · 2022-09-08Effective connectivity of emotion and cognition under psilocybinmedRxiv · 2022-09-08Psychedelics for Alzheimer's Disease Palliative Care.Advances in psychiatry and behavioral health · 2022-08-31Cystathionine Gamma-Lyase Regulate Psilocybin Biosynthesis in Gymnopilus dilepis Mushroom via Amino Acid Metabolism Pathways.Journal of Fungi · 2022-08-17Unraveling the Mysteries of Mental Illness With Psilocybin.Unknown journal · 2022-05-26Effects of psilocybin in relative and global cerebral blood flow and behavioural correlatesNeuroscience Applied · 2021-12-31Investigating cue-reactivity as biomarker for treatment success in psilocybin-assisted therapy for alcohol use disorderNeuroscience Applied · 2021-12-31Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses-A Simultaneous EEG-FMRI Study.Cerebral Cortex · 2021-10-31Mit Psilocybin gegen DepressionInFo Neurologie + Psychiatrie · 2021-07-31Multi-locus identification of Psilocybe cubensis by high-resolution melting (HRM).Forensic Sciences Research · 2021-04-12On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.Unknown journal · 2021-03-10P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlapHuman Brain Mapping · 2020-08-20Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin ExperienceBiomedicines · 2020-02-17Psilocybin Induces Time-Dependent Changes in Global Functional ConnectivityBiological Psychiatry · 2020-01-12Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreatScientific Reports · 2019-10-23In vivo production of psilocybin in E. coliMetabolic Engineering · 2019-09-20Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in micebioRxiv · 2019-08-31Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effectsNeuroImage · 2019-04-05Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.Unknown journal · 2019-01-01Effects of psilocybin on functional connectivity measured with fNIRS: Insights from a single-subject pilot studyZurich Open Repository and Archive (University of Zurich) · 2018-12-31The ethics of psychedelic research in disorders of consciousness.Neuroscience of consciousness · 2018-12-31Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosersPsyArXiv · 2018-11-01Psychedelics, Meditation, and Self-Consciousness.Frontiers in Psychology · 2018-09-03Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.European Neuropsychopharmacology · 2018-04-24Serotonergic Hallucinogen-Induced Visual Perceptual Alterations.Unknown journal · 2017-12-31Phenomenology, Structure, and Dynamic of Psychedelic States.Current topics in behavioral neurosciences · 2017-12-31LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.Frontiers in Pharmacology · 2017-11-07Effect of Psilocybin on Empathy and Moral Decision-Making.The International Journal of Neuropsychopharmacology · 2017-08-31Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow.NeuroImage · 2017-07-11Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination taskEuropean Neuropsychopharmacology · 2016-09-30Hallucinogen Use Disorders.Child and adolescent psychiatric clinics of North America · 2016-06-30Effects of serotonin 2A/1A receptor stimulation on social exclusion processing.Proceedings of the National Academy of Sciences · 2016-04-17Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.European Neuropsychopharmacology · 2016-01-21Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey.Journal of Psychoactive Drugs · 2015-11-22P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteersEuropean Neuropsychopharmacology · 2015-08-31The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.NeuroImage Clinical · 2015-08-21Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations.Psychopharmacology · 2015-07-31P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli - a pharmacological fMRI studyEuropean Neuropsychopharmacology · 2014-09-24Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.Biological Psychiatry · 2014-04-25Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.Cerebral Cortex · 2013-07-15Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.Journal of Neuroscience · 2013-05-31Effects of psilocybin on the human brain functional networkFigshare · 2012-12-31Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual HallucinationsOpen MIND · 2012-12-31The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.Psychopharmacology · 2012-07-26Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.Biological Psychiatry · 2012-05-09Prediction of psilocybin response in healthy volunteers.PLoS ONE · 2012-02-16Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.Unknown journal · 2011-10-25Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.Neuropsychopharmacology · 2011-09-27The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.Biological Psychiatry · 2010-12-02Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.Journal of Psychopharmacology · 2010-09-19Psychometric evaluation of the altered states of consciousness rating scale (OAV).PLoS ONE · 2010-08-30The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.Unknown journal · 2010-08-17Psilocybin slows binocular rivalry switching through serotonin modulationJournal of Vision · 2010-03-18Using psilocybin to investigate the relationship between attention, working memory and the serotonin 5-HT1A and 5-HT2A receptorsJournal of Vision · 2010-03-16Aspects of secondary metabolism in basidiomycetes: I. biological and biochemical studies on Psilocybe cubensis II. a survey of phenol-o-methyltransferase in species of Lentinus and LentinelluscIRcle (University of British Columbia) · 2009-12-31GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studies.Unknown journal · 2008-12-23Serotonin research: contributions to understanding psychoses.Unknown journal · 2008-08-31Effects of the hallucinogenic 5-HT2A agonist psilocybin on object completion in humansInternational Journal of Psychophysiology · 2008-07-16Identification of a serotonin/glutamate receptor complex implicated in psychosis.Unknown journal · 2008-02-23Effects of varied doses of psilocybin on time interval reproduction in human subjects.Neuroscience Letters · 2008-02-08Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.Psychopharmacology · 2007-09-13The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval.Neuropsychopharmacology · 2007-02-13Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.Unknown journal · 2007-01-31Effects of psilocybin on time perception and temporal control of behaviour in humans.Queensland's institutional digital repository (The University of Queensland) · 2006-05-18Severe rhabdomyolysis, acute renal failure and posterior encephalopathy after 'magic mushroom' abuse.European journal of emergency medicine: official journal of the European Society for Emergency Medicine · 2005-11-30Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors.Journal of Cognitive Neuroscience · 2005-09-30Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.Unknown journal · 2005-05-31Psilocybin impairs high-level but not low-level motion perception.Unknown journal · 2004-07-31The Effects of he Hallucinogenic Serotonin 1A/2A Agonist, Psilocybin, on Binocular Rivalry and Visual Contrast Detection ThresholdsQueensland's institutional digital repository (The University of Queensland) · 2003-12-31Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study.Unknown journal · 2003-11-12P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosisEuropean Neuropsychopharmacology · 2003-09-30[Hallucinogens, amphetamines and entactogens].Unknown journal · 2003-05-31A double-blind, placebo controlled study of the effect of the hallucinogenic 5-HT1A&2A agonist psilocybin on binocular rivalry rate and rhythmicitySocial Neuroscience · 2002-12-31Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia.Unknown journal · 2002-12-31Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man.Unknown journal · 2002-08-31Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers.Unknown journal · 2002-02-28Brain mechanisms of hallucinogens and entactogens.Unknown journal · 2001-11-30A systems model of altered consciousness: integrating natural and drug-induced psychoses.Unknown journal · 2001-10-315-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.Unknown journal · 1999-04-30Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.Unknown journal · 1998-11-30Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research.Unknown journal · 1998-06-3011C-radiolabeling of hallucinogenic psilocin, a potential radioligand for studying the role of serotonin receptors in psychotic symptom formationJournal of Labelled Compounds and Radiopharmaceuticals · 1998-06-30Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man.Unknown journal · 1997-05-31Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.Unknown journal · 1997-04-30Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.Unknown journal · 1996-06-30Defining the histamine H2-receptor in brain: the interaction with LSD.Unknown journal · 1977-12-31A new behavior change program using psilocybin.Psychotherapy · 1964-12-31Studies on psilocybin and related compounds. I. Communication. Structure/activity relationship of oxyindole-derivatives with regard to their effect on the knee jerk of spinal cats.Unknown journal · 1959-12-31[The pharmacology of psilocybin, an ac' principle from Psilocybe mexicana Heim].Unknown journal · 1958-08-31